OYMotion Technologies secured nearly RMB 100 million in its Series C funding round.   The funding round was led by Intelligent Interconnection Industry Fund, a subsidiary of Qianhai Ark Industrial Fund, and Zhongyuan Qianhai Fund. XingTuo Capital, Zhang Yang, Chairman of Sanbo Brain and well-known investor in neuroscience, and the founder of Shanghai Deji Hospital / Shanghai Brain Medical Center at Qingdao University also participated in the investment. 

CEC Capital Group acted as the exclusive financial advisor to OYMotion Technologies in this transaction. 

This injection of capital will empower OYMotion Technologies to rapidly build its neuroscience and neural interface tech platform, bolstering its R&D and manufacturing prowess in robotics. It will further expedite the creation and clinical advancement of neural rehabilitation exoskeletons and champion the global commercialization of its advanced, intelligent bionic hands.

OYMotion Technologies is a leading Chinese company in the forefront of brain electromyography and neural interface technology. By integrating brain-machine interface, electromyography neural interface, artificial intelligence, and exoskeleton robotics, the company has applied its cutting-edge technologies to a diverse range of products, including neural rehabilitation exoskeleton robots, advanced intelligent bionic hands, and EEG machines, establishing itself as a platform-based neuroscience technology company.